The Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.
Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increased Prevalence of Obesity across the Region
Every country in the Middle East & Africa region is currently facing an increasing prevalence of obesity due to multiple factors. A sedentary lifestyle and unhealthy eating habits contribute majorly to obesity in an individual. Along with a lack of physical activity and mounting stress are contributing as well. According to a report ‘2018ReviewEnd-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis’, it is estimated that the annual cost for CKD and ESRD is $48 billion and $32.9 billion and is rising due to cases of obesity.As perthe report ‘Chronic Kidney Disease in Arab World: A Call for Action,’obesity is also related to CKD epidemiology since obesity appears to be an essential risk factor for CKD. The prevalence of obesity has increased over the past two decades. Over 3,000 million adults worldwide are obese. The majority of a body mass index of at least 35 among incident dialysis patients has increased by 64% over the past decade. If trends continue, 20% of all patients will initiate dialysis with this degree of obesity. In Syria, obesity was 38.2%, with the prevalence in women nearly one and half times more than in men. Obesity affects 16–50% of individuals with diabetes in the Arab world, 20–38% have hyperlipidemia, 24–46% have hypertension and, although data are incomplete, nephropathy and retinopathy rates appear to be relatively high. Moreover, in a review of obesity prevalence in the Arab world, it was concluded that one-third of Arabs are obese, and women have notably higher rates of obesity as defined by a body mass index of 30.Thus, an increase in the prevalence of obesity in the Middle East & Africa region is likely to create lucrative opportunities for market growth.
Product- Based Market Insights
Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
End-User - Based Market Insights
Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Middle East and Africa Kidney Disease Market: Strategic Insights
Market Size Value in US$ 4,834.1 Million in 2019 Market Size Value by US$ 7,406.2 Million by 2027 Growth rate CAGR of 5.5% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Middle East and Africa Kidney Disease Market: Strategic Insights
Market Size Value in | US$ 4,834.1 Million in 2019 |
Market Size Value by | US$ 7,406.2 Million by 2027 |
Growth rate | CAGR of 5.5% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystProduct launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the kidney disease market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance,In February 2017,Amgen received approval for its Parsabiv (Etelcalcetide) to treat secondary hyperparathyroidism in adult patients suffering from chronic kidney disease on hemodialysis. It is the first therapy that is approved the indication in about 12 years. And it is the only calcimimetic that can be administered intravenously to the patients during dialysis.
MIDDLE EAST & AFRICAKIDNEY DISEASE MARKET SEGMENTATION
- Diagnosis
- Blood Tests
- Urine Tests
- Imaging Tests
- Others
- Treatment
- Dialysis
- Others
- Drug Class
- ACE Inhibitors
- Angiotensin-II Receptor Blockers
- Diuretics
- Others
- Hospitals
- Diagnostic Laboratories
- Others
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
Company Profiles
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVieInc
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Sysmex Corporation
- Siemens AG
- Amgen Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market – By Product
1.3.2 Kidney Disease Market – By End User
1.3.3 Middle East & AfricaKidney Disease – By Country
2. Middle East & Africa Kidney Disease – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Kidney Disease – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Kidney Disease Market- Middle East & Africa PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Kidney Disease - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Diabetes Resulting inRenal Diseases
5.1.2 Rising Incidences of Renal Diseases
5.2 Market Restraints
5.2.1 The constraint of Finance and Resources in Developing Countries
5.3 Market Opportunities
5.3.1 Increasing Prevalence of Obesity across the Region
5.4 Future Trends
5.4.1 Better Government Initiatives for Kidney Disease Market
5.5 Impact Analysis
6. Kidney Disease Market – Middle East & Africa Analysis
6.1 Middle East & AfricaKidney Disease Revenue Forecasts and Analysis
7. Middle East & Africa Kidney Disease Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8. Middle East & AfricaKidney Disease Analysis – By End-User
8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
9. Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Middle East & Africa: Kidney Disease Market
9.1.1 Overview
9.1.2 Middle East & Africa: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
9.1.3 Middle East and Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Middle East and Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Middle East and Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.3.2.1 Middle East and Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.4 Middle East and Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.5 Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)
9.1.6 Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Saudi Arabia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 Saudi Arabia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 Saudi Arabia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 Saudi Arabia: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Saudi Arabia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.7 UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UAE: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 UAE: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 UAE: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 UAE: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 UAE: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.8 South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 South Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 South Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 South Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2.1 South Africa: Kidney Disease Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)
9.1.8.3 South Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Middle East & AfricaKidney Disease
10.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Sysmex Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Fresenius SE & Co. KGaA
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Siemens AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
Source: Press Release, Newsletters, and Company Annual Report
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of terms
LIST OF TABLES
Table 1. Middle East and Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East and Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East and Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 5. Middle East and Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Saudi Arabia: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 8. Saudi Arabia: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 9. Saudi Arabia: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. Saudi Arabia: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. UAE: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 12. UAE: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 13. UAE: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 14. UAE: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. UAE: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. South Africa: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 17. South Africa: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)
Table 18. South Africa: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 19. South Africa: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 20. South Africa: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms,Kidney disease
LIST OF FIGURES
Figure 1. Kidney Disease Segmentation
Figure 2. Middle East & Africa Kidney Disease Overview
Figure 3. Diagnosis Segment Held Largest Share of Product in Kidney Disease Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Kidney Disease Market - Middle East & Africa PEST Analysis
Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints
Figure 7. Middle East & Africa Kidney Disease – Revenue Forecasts and Analysis – 2019- 2027
Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)
Figure 9. Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)
Figure 23. Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Middle East & Africa: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. Middle East & Africa Kidney Disease Market Revenue and Forecast to 2027 (USD Million)
Figure 28. Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)
Figure 29. Saudi Arabia: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. UAE: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. South Africa: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Middle East & Africaon Country Markets
The List of Companies - Middle East and Africa Kidney Disease Market
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVieInc
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Sysmex Corporation
- Siemens AG
- Amgen Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Kidney Disease Market
Nov 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)